Thinking of Buying CRISPR Therapeutics Stock? Watch These 2 Key Numbers
Biotechs like CRISPR Therapeutics (NASDAQ: CRSP) can be tricky to invest in, as it isn’t always obvious whether management’s plans are working or not. Simply focusing on a big-picture figure like revenue often misses key points about what the company has done and where it’s going